Ivan De Kouchkovsky, MD
Assistant Clinical Professor, Div. of Hematology & Oncology, UCSF
Education
- University of California, Berkeley, BA, 2011, Philosophy
- New York University, MD, 2016, Medicine
- University of California, San Francisco, Internship, 2017, Internal Medicine
- University of California, San Francisco, Residency, 2019, Internal Medicine
- University of California, San Francisco, Fellowship, 2022, Hematology/Oncology
Honors & Awards
- 2018
Clinical & Translational Science Institute Resident Research Training Program Travel Award, UCSF - 2021
American Society of Clinical Oncology Conquer Cancer Merit Award - 2021
Young Investigator Award, American Society of Clinical Oncology - 2021
Ronald A. Rosenberg Endowed Fellowship in Genitourinary Medical Oncology - 2021
Young Investigator Award, Prostate Cancer Foundation
Selected Publications
- Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal R, Small EJ, Fong L, Chou J, Friedlander T, de Kouchkovsky I, Koshkin VS. Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin. Clin Genitourin Cancer. 2023 10; 21(5):e394-e404. View on PubMed
- de Kouchkovsky I, Chen HY, Ohliger MA, Wang ZJ, Bok RA, Gordon JW, Larson PEZ, Frost M, Okamoto K, Cooperberg MR, Kurhanewicz J, Vigneron DB, Aggarwal R. Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer. Eur Urol. 2022 02; 81(2):219-221. View on PubMed